Tonix Other Assets from 2010 to 2024

TNXP Stock  USD 0.19  0.01  5.00%   
Tonix Pharmaceuticals Other Assets yearly trend continues to be relatively stable with very little volatility. Other Assets are likely to drop to about 419.5 K. During the period from 2010 to 2024, Tonix Pharmaceuticals Other Assets destribution of quarterly values had range of 51.8 M from its regression line and mean deviation of  6,415,706. View All Fundamentals
 
Other Assets  
First Reported
2011-06-30
Previous Quarter
292 K
Current Value
1
Quarterly Volatility
19 M
 
Yuan Drop
 
Covid
Check Tonix Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tonix Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 9.6 M, Selling General Administrative of 36.5 M or Gross Profit of 3.2 M, as well as many indicators such as Price To Sales Ratio of 0.7, Dividend Yield of 0.44 or PTB Ratio of 0.0683. Tonix financial statements analysis is a perfect complement when working with Tonix Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Tonix Pharmaceuticals Correlation against competitors.

Latest Tonix Pharmaceuticals' Other Assets Growth Pattern

Below is the plot of the Other Assets of Tonix Pharmaceuticals Holding over the last few years. It is Tonix Pharmaceuticals' Other Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tonix Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Other Assets10 Years Trend
Pretty Stable
   Other Assets   
       Timeline  

Tonix Other Assets Regression Statistics

Arithmetic Mean3,733,208
Geometric Mean277,268
Coefficient Of Variation356.70
Mean Deviation6,415,706
Median189,000
Standard Deviation13,316,200
Sample Variance177.3T
Range51.8M
R-Value0.26
Mean Square Error178.3T
R-Squared0.07
Significance0.35
Slope767,283
Total Sum of Squares2482.5T

Tonix Other Assets History

2024419.5 K
2023441.6 K
2022384 K
202151.9 M
20201.5 M
2016100 K
2015189 K

About Tonix Pharmaceuticals Financial Statements

Tonix Pharmaceuticals shareholders use historical fundamental indicators, such as Other Assets, to determine how well the company is positioned to perform in the future. Although Tonix Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Tonix Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Tonix Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Assets441.6 K419.5 K

Pair Trading with Tonix Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tonix Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tonix Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Tonix Stock

  0.61VALN Valneva SE ADRPairCorr

Moving against Tonix Stock

  0.63NXGLW NexGel WarrantPairCorr
The ability to find closely correlated positions to Tonix Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tonix Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tonix Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tonix Pharmaceuticals Holding to buy it.
The correlation of Tonix Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tonix Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tonix Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tonix Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Tonix Stock Analysis

When running Tonix Pharmaceuticals' price analysis, check to measure Tonix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tonix Pharmaceuticals is operating at the current time. Most of Tonix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tonix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tonix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tonix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.